TY  - JOUR
AU  - Sarabia De Ardanaz, Luis
AU  - Andreu-Ubero, Jose M.
AU  - Navidad-Fuentes, Miriam
AU  - Ferrer-González, Miguel Ángel
AU  - Ruíz Del Valle, Victor
AU  - Salcedo-Bellido, Inmaculada
AU  - Barrios-Rodríguez, Rocío
AU  - Cáliz-Cáliz, Rafael
AU  - Requena, Pilar
PY  - 2021
DO  - 10.3389/fphar.2021.620187
UR  - http://hdl.handle.net/10668/3484
T2  - Frontiers in Pharmacology
AB  - Tocilizumab (TCZ) has been administered in SARS-CoV-2 pneumonia but the factors associated with mortality before and after treatment remain unclear. Cox regression models were used to estimate the predictors of time to death in a cohort of...
LA  - en
PB  - Frontiers Research Foundation
KW  - COVID-19
KW  - Immunosupression
KW  - Tocilizumab
KW  - Mortality
KW  - Risk factor
KW  - Platelet
KW  - Mortalidad
KW  - Factores de riesgo
KW  - Plaquetas
KW  - Medical Subject Headings::Diseases::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections
KW  - Medical Subject Headings::Phenomena and Processes::Physical Phenomena::Time::Time Factors
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Patient Care::Hospitalization::Patient Discharge
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Confidence Intervals
KW  - Medical Subject Headings::Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Glucose Metabolism Disorders::Diabetes Mellitus
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Cytological Techniques::Cell Count::Blood Cell Count::Platelet Count
TI  - Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment
TY  - research article
ER  -